| Name | Title | Contact Details |
|---|
American Pathology Partners (AP2) company career center! We appreciate your interest in career opportunities with us and encourage you to explore our site to learn more about us and our partner laboratories in Colorado (UniPath), Florida (Palm Beach Pathology), North Carolina (Eastern Carolina Pathology). We are committed to building long-term partnerships within the communities we serve through service excellence and our commitment to the latest in technological innovation. Our pathologist partners are valued leaders within our affiliated laboratories and deliver specialized anatomic and molecular pathology services within their local and regional healthcare markets. As a growing organization, we offer a diversity of laboratory positions in histology, grossing, flow cytometry, cytology processing, molecular as well as career opportunities in finance, sales, information technology and human resources. We offer a competitive salary and excellent benefits package including Medical, Dental, Vision, Life, Long-Term Disability, Flexible Spending Accounts, and a Tuition Reimbursement Program. In addition, we support ongoing educational programs and career opportunities; provide liberal Paid Time Off benefits; and offer a generous Retirement 401(k) plan.
EKOS Corporation was founded in 1995 with the vision that ultrasound could accelerate the delivery of drugs to benefit patients with a variety of diseases and conditions. Today, EKOS is the world leader in providing ultrasound-assisted, fluid infusion
Since 2002, Legacy Senior Living has specialized in operating Independent Living, Assisted Living & Memory Care facilities throughout the southeast. Founded with a purpose to serve the greatest generation, Legacy take`s the calling seriously, knowing that each resident and family member deserves the highest quality care. Legacy Seeks to serve with honor, respect, faith and integrity through specific programs: Standards of Service, "Going the Extra Mile", and Quality Assurance Programs.
AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering and developing targeted therapies designed to provide substantial impact in patients` lives with clear unmet medical needs. AVEO`s proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics.
Providing the world`s best healthcare to everyone